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Mixed modality treatment planning of
Accelerated Partial Breast Irradiation:
to improve complex dosimetry cases
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Background: Although 3D-conformal accelerated partial breast irradiation (APBI) is widely used, several questions
still remain such as what are the optimal treatment planning modalities. Indeed, some patients may have an
unfavorable anatomy and/or inadequate dosimetric constraints could be fulfilled ("complex cases”). In such cases,
we wondered which treatment planning modality could be applied to achieve 3D-conformal APBI (2 mini-tangents
and an “en face” electron field or non-coplanar photon multiple fields; or a mixed technique combining non-
coplanar photon multiple fields with an “en face” electron beam).
Methods: From October 2007 to March 2010, 55 patients with pT1N0 breast cancer were enrolled in a phase II
APBI trial. Among them, 7 patients were excluded as they were considered as “complex cases”. A dosimetric
comparison was performed according to the 3 APBI modalities mentioned above and assessed: planning treatment
volume (PTV) coverage, PTV/whole breast ratio, lung and heart distance within irradiated field and exposure of
organs at risk (OAR).
Results: Adequate PTV coverage was obtained with the 3 different treatment planning. Regarding OAR exposure,
the “mixed technique” seemed to reduce the volume of non-target breast tissue in 4 cases compared to the other
techniques (in only 1 case), with the mean V50% at 44.9% (range, 13.4 - 56.9%) for the mixed modality compared to
51.1% (range, 22.4 - 63.4%) and 51.8% (range, 23.1 - 59.5%) for the reference and non-coplanar techniques,
respectively. The same trend was observed for heart exposure.
Conclusions: The mixed technique showed a promising trend of reducing the volume of non-target breast tissue
and heart exposure doses in APBI “complex cases”.
Keywords: 3D-conformal accelerated partial breast irradiation, Dosimetric optimization
Introduction
While whole breast irradiation (50 Gy/25 fractions) fol-
lowed by a boost to the tumor bed (16 Gy/8 fractions)
is the standard of locoregional care for early breast
cancer, the current trend is to shorten overall treat-
ment time by delivering either hypofractionated whole
breast irradiation (WBI) or accelerated partial breast
irradiation (APBI). The latter technique has gained
momentum and has been widely used since the
American and European Societies of Radiation Oncol-
ogy suggested that a breast cancer population would
benefit from APBI outside of any clinical trial [1,2].
However, several issues still need to be clarified such
as the optimal APBI techniques (invasive or non inva-
sive), treatment planning modalities for 3D-conformal
APBI (non-coplanar fields [3], mixed electron-photon
beams [4]), the optimal total dose and dosimetric con-
straints that would limit late side effects.
At the Institut Gustave Roussy, we recently reported
the early results of a 3D-conformal APBI trial [5] in
which treatment planning was performed according to
the technique designed by Taghian and colleagues,
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consisting of 2 mini-tangents and an “en face” electron
field contributing around 20% of the total dose (8 Gy)
[4,6]. The design of this phase II dose escalation trial
was to deliver a total dose of 40 Gy in 10 fractions
over 5 days (40 Gy step) and 44 Gy in 10 fractions
over 5 days (44Gy step). Among 55 patients enrolled
since October 2007, 7 patients were excluded for
inadequate 3D-conformal APBI treatment planning
and/or for an unfavourable anatomy. Here we investi-
gated whether these latter patients, called “complex
cases” could be treated with 3D-conformal APBI using
other irradiation modalities, either by non-coplanar
photon multiple fields [3] or by a mixed technique
combining non-coplanar photon multiple fields with
an “en face” electron beam. Both of these techniques
were compared to the APBI modality used in the
phase II trial [4,6].
Materials and methods
Study population
The study population consisted of 55 women referred
for adjuvant radiotherapy and treated with APBI from
October 2007 to March 2010. All patients were prospec-
tively enrolled on an institutional and national review
board-approved Phase II trial. The patient population
was previously described elsewhere [5,6]. Among these
55 patients, 7 patients were excluded for inadequate 3D-
conformal APBI treatment planning and/or for an unfa-
vorable anatomy. The 3D-conformal APBI treatment
plan was considered inadequate when the ratio of the
Planning Treatment Volume (PTV) over the Whole
Breast (WB) was higher than 25%. An unfavorable anat-
omy was defined as high lung or heart exposure
observed within the radiation field such as a maximum
lung distance exceeding 2 cm, or a maximum heart dis-
tance greater than 1 cm.
Simulation and treatment planning
All patients underwent a CT breast simulation (Siemens
SOMATOM Sensation Open/Siemens Navigator/
SOMARIS/5 Syngo) in the treatment position. Patients
were in the supine position on an inclined breast board
(Med Tec/Model MT-350-N) with both arms raised
above the head. The clinical mammary gland borders,
the lumpectomy scar and the post-surgical indurations
were outlined with radio-opaque wires. The scans
extended approximately from the neck to the upper
abdomen in 2-mm thick slices. Then, CT data were
transmitted on-line to the virtual simulation system.
The ipsilateral breast, the ipsilateral and contralateral
lungs, and the heart (from the base up to the level of
the pulmonary artery bifurcation) were contoured and
were considered as organs at risk. The CTV was defined
as the delineation of the visible lumpectomy cavity and
the surgical clips were placed inside the lumpectomy
cavity according to the surgical placement procedure (4
clips were placed at the upper, inner, outer and lower
surgical margins of the tumor bed) [7,8]. The PTV was
uniformly expanded by 1.5 to 2.0 cm around the CTV
to which an additional 8 mm expansion was included
for penumbra. The skin (the first 5 mm beneath the epi-
dermis) and the anterior chest wall/pectoralis muscles
were excluded from the PTV.
Three different treatment planning modalities were
subsequently performed: (i) the 3D-conformal APBI
modality used in the phase II trial [4,6]; (ii) non-copla-
nar photon multiple fields according to the technique
designed by Vicini and colleagues [3] and (iii) a mixed
modality combining non-coplanar photon multiple fields
with an en face electron beam (Figure 1). Then, a com-
parative dosimetric study was performed to assess the
optimal 3D-conformal APBI technique in order to
reduce organ at risk exposure (breast, lung and heart)
and/or to improve PTV coverage.
Results
Patient and tumor characteristics are reported in Table 1.
Median age was 63 years (range, 56 - 76). The median
tumor size was 6 mm (range, 4 - 11 mm), the median lum-
pectomy cavity size was 41 cm3 (range, 9 - 90 cm3). The
median CTV and PTV was 13.6 cm3 (range, 3.1 - 64.9)
and 110.4 cm3 (range, 35.2 - 304.1 cm3), respectively. The
tumor was located in the upper outer (n = 2), upper inner
(n = 1), lower inner (n = 2) quadrants, union of the lower
(n = 1) and of the inner (n = 1) quadrants.
Dosimetric comparison (Table 2). PTV coverage was
adequate whatever the 3D-APBI technique used. In con-
trast, only the mixed modality 3D-APBI technique
allowed us to reduce the volume of breast exposure
with a mean V50% at 44.9% (range, 13.4 - 56.9%) com-
pared to 51.1% (range, 22.4 - 63.4%) and 51.8% (range,
23.1 - 59.5%) for the reference and non-coplanar techni-
ques, respectively.
Large tumor bed volume (Figure 2). Three patients had
a PTV/whole breast ratio equal to or higher than 25%
(one at 25% and the other two at 30%) leading to a
whole breast V20Gy exceeding 50%. We wondered
whether a non coplanar and mixed technique would les-
sen exposure of breast tissue compared to the technique
used in the phase II trial. Whatever the treatment plan-
ning, a large PTV/whole breast ratio implied high breast
exposure, with a whole breast V20Gy exceeding 50%
(range, 54.4% - 63.4%). Nevertheless, the mixed modality
seemed to decrease breast exposure compared to the
other techniques but no improvement was shown
regarding heart and lung exposure (Table 3).
Unfavorable Anatomy (Figure 3). Four patients had an
unfavorable anatomy with a mean lung distance
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exceeding 2 cm (n = 4) and a mean heart distance larger
than 1 cm (n = 2). Heart exposure was largely greater
(at least x3) in case of an unfavorable anatomy with V5
Gy, V10 Gy and V20 Gy ranging from 13.1 - 15.7%; 9.3 -
11.1% and 3.1 - 9.3%, respectively rather than after usual
3D-conformal APBI treatment planning with V5 Gy, V10
Gy and V20 Gy ranging from 0.0 - 4.1%, 0.0 - 1.0% and
0.0 - 0.5%, respectively. The use of other APBI techni-
ques allowed a decrease in heart exposure.
Discussion
The present study showed that PTV coverage is optimal
whatever the 3D-conformal APBI techniques with a
trend towards decreasing the volume of non-target
breast tissue using the mixed-APBI technique. An unfa-
vorable anatomy and/or inadequate 3D-conformal APBI
treatment planning concern a small percentage of the
breast cancer population with a low risk of local relapse.
The use of non-coplanar or mixed-modality APBI
A B 
C 
Figure 1 Digitally reconstructed, skin-rendered view showing projections of 3D-conformal APBI modality (A) used in the phase II trial,
i.e. two mini-tangents and one en face electron field; (B) according to the technique designed by Vicini and colleagues, i.e. non-
coplanar photon multiple fields and (C) as a mixed modality combining non-coplanar photon multiple fields with an en face electron
beam.
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techniques seemed to lessen the exposure of organs at
risk (OAR).
The occurrence of radio-induced pneumonitis after
breast-conserving irradiation has been extensively stu-
died and is estimated at 5% for a mean lung dose
(MLD) at 7 Gy, at 10% for a MLD at 13 Gy and at
20% for a MLD at 20 Gy whatever the breast, chest
wall and/or nodal irradiation [9]. Other risk factors for
radiation pneumonitis have been reported after whole
breast irradiation such as the central lung distance
[10]. The present study showed that some patients had
an unfavorable anatomy with a mean lung distance
exceeding 2 cm. As the APBI concept is aimed at
reducing OAR exposure, we considered that patients
presenting with a large lung distance in APBI fields
should be excluded from the clinical trial even if the
ipsilateral lung volume was adequate. Few cases of
radio-induced pneumonitis have been reported after
3D-conformal APBI [11]. Recht and colleagues
observed four cases of pneumonitis during the first
year following APBI completion which seemed to be
related to ipsilateral lung exposure. Thus, the risk of
radio-induced pneumonitis was estimated at 17% when
3% of the ipsilateral lung volume received at least 20
Gy (ILV20 Gy); at 20% when more than 10% of the ipsi-
lateral lung volume received a dose of at least 10 Gy
(ILV10 Gy) and at 15% when 20% of the ipsilateral lung
volume received 5 Gy [ILV5 Gy] [11]. The authors sta-
ted that the ipsilateral lung volume could be reduced
by using mixed photon-electron techniques when pos-
sible. Similar conclusions were recently reached [12]
regarding the reduction of ipsilateral lung exposure by
combining electron and photon beams.
The heart is the main critical organ at risk when adju-
vant radiotherapy is delivered for early breast cancer.
The Early Breast Cancer Trialists’ Collaborative Group
(EBCTCG) meta-analysis showed a significant 27%
increase in mortality related to heart diseases after
breast irradiation [13]. Many studies highlighted the role
of a high dose per fraction and heart volume exposure
in radiation-induced heart diseases [14,15]. To date, no
heart disease has been reported in APBI clinical trials
because the duration of follow-up is short. Indeed, heart
diseases occur many years after irradiation completion
(> 10 years) [13]. Even if the 3D-conformal APBI
appears to be the best irradiation technique for patients
with a highly unfavorable cardiac anatomy compared to
whole breast irradiation [WBI] [16], in some cases,
neither technique (WBI or APBI) seems to be adequate
for a few patients such as those in our present study.
Two of them had an unfavorable anatomy with high
heart exposure after treatment planning with 3D-confor-
mal APBI. The use of non-coplanar fields or mixed
modalities reduced heart exposure.
Some unacceptable toxicities have been reported after
3D-conformal APBI [17,18] raising the question of its
safety in terms of late toxicities. Here, the critical point
is related to exposure of the non-target breast volume.
Indeed, the more the breast is exposed to low doses
within large volumes, the greater the severity of fibrosis
[17]. In addition, a large PTV/WB ratio and large clini-
cal target and treatment planning volumes contributed
to an increased risk of severe fibrosis and poor/fair
cosmesis [17,18]. A large CTV is usually related to large
seroma after breast surgery which generally decrease
over time [19]. Breast remodeling during breast-conser-
ving surgery increases clinical target and treatment plan-
ning volumes, as in the present cases. In addition, a 5
mm expansion of the PTV increases the volume receiv-
ing 100% of the total dose by 1-2% and the volume
receiving 75%, 50% and 25% of the total dose by 6-7%
[20]. Thus, the authors stated that higher doses were
delivered to normal breast tissue due to the enlargement
of the PTV around the lumpectomy cavity.
Table 1 Patient and tumor characteristics (CTV: Clinical
Target Volume; PTV: Planning Treatment Volume; WB:
Whole Breast)










Median tumor size (min - max) (mm) 7 (4 - 11)
Mean excision cavity size (min - max) (cm3) 44 (9 - 90)
Median CTV (min - max) (cm3) 13.61 (3.07 - 64.88)
Median PTV (min - max) (cm3) 110.41 (35.2 - 304.10)
Unfavorable anatomy (number of patients) 4/7
Large PTV/WB ratio (number of patients) 3/7























Mean PTV/WB ratio 21.4%
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Finally, other external beam - APBI techniques
could be used to lessen OAR exposure. Volumetric
Modulated Arc Therapy (VMAT) has been recently
described as a new APBI modality which is capable of
significantly decreasing irradiated ipsilateral lung and
breast volumes compared to 3D-conformal APBI,
with a lesser mean value of total Monitor Units [21].
In addition to reducing OAR exposure, intra-
operative partial breast irradiation could be per-
formed [22].
Conclusion
Complex cases such as an unfavorable anatomy and or
inadequate dosimetric constraints are infrequent in the
APBI setting. In such cases, efforts should be made to
assess different APBI treatment planning modalities in
order to choose the best technique for adequate PTV cov-
erage and to lessen OAR exposure. Although the size of
the study is small, the mixed technique showed a promis-
ing trend towards decreasing breast and non-target breast
tissue doses but did not allow a decrease in lung doses.
   
(A)                                                                                                         (B) 
Figure 2 Example of a large PTV/whole breast ratio. (a) Medial Minitangent field; (b) Lateral minitangent field, targeting the PTV (Heart in
red, Ipsilateral lung in blue, Contralateral lung in pink and Mammary gland in green).
Table 3 Patients with a large tumor bed volume: Whole Breast (WB) and Planning Treatment Volume (PTV) exposure






Patient 1 Patient 2 Patient 3 Patient 1 Patient 2 Patient 3 Patient 1 Patient 2 Patient 3
V16 24 - 57 56.4 64.6 58.3 63.8 61.6 62.8 61.2 58.9 62.4
V20 23 - 54 54.4 63.4 56.1 58.9 57.1 59.5 51.4 52.2 56.9






Patient 1 Patient 2 Patient 3 Patient 1 Patient 2 Patient 3 Patient 1 Patient 2 Patient 3
V38 99 - 100 93.5 100 100 100 100 100 99.9 99.9 100
V40 95 - 100 60.6 93.5 98.7 99.3 100 99.2 95.3 94.5 96.7
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